Cellvizio to Evaluate Margins in Crohn's Ileal Disease (CELLVICROHN)
Crohn Disease, Resection Margins, Recurrence
About this trial
This is an interventional diagnostic trial for Crohn Disease focused on measuring Crohn Disease, Resection Margins, recurrence
Eligibility Criteria
Inclusion Criteria: Patients who need a ileocaecal resection for a Crohn disease whatever is the phenotype of the Crohn's disease Exclusion Criteria: Patients<18 years old, pregnancy or breastfeeding, patients who have an ileocolic resection for a surgical recurrence of the Crohn's disease. Patients operated in emergency for a peritonitis, patients who have a contra-indication for fluorescein injection or severe allergia to any drug
Sites / Locations
- CHU Amiens PicardieRecruiting
Arms of the Study
Arm 1
Experimental
Cellvizio
Cellvizio is a confocal laser endomicroscopy providing the possibility of obtaining in vivo high-magnification images of the gut epithelium. This allows real-time examination of the gastrointestinal mucosa at the cellular and subcellular level